Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study.

Cancer communications (London, England)·2018
Same author

[Expression of Nerve Growth Factor and Type 3 of Acid Sensitive Ion Channels in Rat Model of Type Ⅲ Prostatitis].

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition·2018
Same author

[Expression of AXIN and MACC1 in Gastric Carcinoma and Its Clinical Significance].

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition·2018
Same author

Coexistence of NDM-1-producing Escherichia coli and Citrobacter freundii in the same patient.

Journal of global antimicrobial resistance·2018
Same author

Broadband microwave absorption utilizing water-based metamaterial structures.

Optics express·2018
Same author

TWIST1 upregulates miR-214 to promote epithelial-to-mesenchymal transition and metastasis in lung adenocarcinoma.

International journal of molecular medicine·2018

Related Experiment Video

Updated: Dec 28, 2025

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

6.9K

A pooled analysis of primary hepatic angiosarcoma.

Dong Zeng1, Jianan Cheng1, Zhihua Gong1

  • 1Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, P.R. China.

Japanese Journal of Clinical Oncology
|February 22, 2020
PubMed
Summary
This summary is machine-generated.

Primary hepatic angiosarcoma is a rare cancer. This study highlights that surgery combined with chemotherapy improves outcomes, while liver transplantation is not recommended for this aggressive neoplasm.

Keywords:
primary hepatic angiosarcomaprognosissurgerytreatment

More Related Videos

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.8K
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

42.5K

Related Experiment Videos

Last Updated: Dec 28, 2025

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

6.9K
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.8K
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

42.5K

Area of Science:

  • Oncology
  • Hepatobiliary Surgery
  • Cancer Research

Background:

  • Primary hepatic angiosarcoma is an extremely rare and aggressive malignant neoplasm, accounting for approximately 5% of all angiosarcomas.
  • Limited physician awareness of this rare condition necessitates further investigation into its characteristics, treatment, and prognosis.

Purpose of the Study:

  • To systematically review and analyze the main characteristics, demographics, treatment strategies, and survival outcomes of primary hepatic angiosarcoma.
  • To provide an updated overview of the largest cohort of primary hepatic angiosarcoma patients to date.

Main Methods:

  • A systematic literature review was conducted, analyzing studies published worldwide between 1990 and 2019.
  • Data from 219 patients diagnosed with primary hepatic angiosarcoma were included in the analysis.

Main Results:

  • The average age at diagnosis was 56.7 years, with abdominal pain or distension being the most common presenting symptom (61.5%).
  • The median overall survival was 6 months, with 1- and 2-year survival rates of 30.4% and 17.3%, respectively. Hepatic rupture was a significant negative predictor of survival.
  • Surgery is a primary treatment, and adjuvant chemotherapy can improve prognosis. Hepatic artery embolization is used for rupture, but liver transplantation is not advised.

Conclusions:

  • Routine physical examinations and surgical intervention combined with adjuvant chemotherapy are recommended to improve outcomes for primary hepatic angiosarcoma.
  • This study provides a comprehensive overview of demographics, tumor characteristics, and treatment outcomes, emphasizing the need for increased awareness and optimized management strategies.